Aster Capital Management’s Innospec IOSP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$78.5K Sell
965
-665
-41% -$52.6K 0.02% 513
2026
Q1
$154K Buy
1,630
+1,559
+2,196% +$121K 0.05% 271
2025
Q4
$5.43K Sell
71
-78
-52% -$5.89K ﹤0.01% 858
2025
Q3
$11.5K Buy
+149
New +$12.4K 0.01% 731
2025
Q2
Sell
-3,266
Closed -$338K 1299
2025
Q1
$338K Buy
+3,266
New +$346K 0.06% 364
2024
Q4
Sell
-17
Closed -$1.92K 1302
2024
Q3
$1.92K Buy
+17
New +$1.98K ﹤0.01% 981

Other funds holding IOSP

Aster Capital Management's IOSP Position: Q2 2026 in Review

Aster Capital Management reduced its Innospec (IOSP) stake by 41% in Q2 2026, selling an estimated $52.6K and leaving 965 shares worth $78.5K. The position accounts for 0.02% of the portfolio, ranked #513.

Aster Capital Management first reported a position in IOSP in Q3 2024 and has held it in 6 quarters since. The position peaked at $338K in Q1 2025. 281 funds tracked by Wall St. Rank hold IOSP as of Q2 2026.

  • Aster Capital Management held 965 shares of Innospec worth $78.5K as of Q2 2026.
  • Aster Capital Management sold 665 Innospec shares in Q2 2026, an estimated $52.6K.
  • Innospec made up 0.02% of Aster Capital Management's portfolio in Q2 2026, its #513 holding.
  • Aster Capital Management first reported a position in Innospec in Q3 2024 and has held it in 6 quarters since.
  • Aster Capital Management's Innospec position peaked at $338K in Q1 2025.
  • 281 funds tracked by Wall St. Rank held Innospec as of Q2 2026.

Based on Aster Capital Management's 13F filing for Q2 2026, filed 13 Aug 2026.